Ablepharon Macrostomia Syndrome C1860224 vs 17 20 Lyase Deficiency Isolated Included CN372394

Choose Ablepharon Macrostomia Syndrome C1860224 when

• Newborn with absent or rudimentary eyelids and macrostomia

  These congenital findings align with the supplied description of ablepharon-macrostomia syndrome.

  High

• Need for coordinated craniofacial and eye protection planning

  The described facial anomalies imply specialized surgical and medical care rather than hormone replacement alone.

  Moderate

• Suspected rare congenital syndrome without a primary steroid abnormality

  The supplied category is rare congenital disease, not an endocrine disorder.

  Moderate

Choose 17 20 Lyase Deficiency Isolated Included CN372394 when

• Child or adolescent with undervirilization or absent puberty

  Isolated 17,20-lyase deficiency primarily affects sex-steroid production and may present from birth through age 16.

  Moderate

• Endocrine evaluation suggests impaired androgen and estrogen synthesis

  The condition belongs to steroid biosynthesis disorders rather than craniofacial malformation syndromes.

  Moderate

• No characteristic eyelid or mouth anomaly is present

  Absence of the supplied craniofacial features makes ablepharon-macrostomia syndrome less likely, but does not prove the endocrine diagnosis.

  Low

Ablepharon Macrostomia Syndrome C1860224

Outcome

A chronic, potentially severe congenital condition requiring specialized care; survival and function are not quantified here.

Factors

Extent of eyelid, mouth, and associated anomalies, plus access to coordinated care.

17 20 Lyase Deficiency Isolated Included CN372394

Outcome

A chronic endocrine condition whose outcome depends on timely recognition and management; specific outcomes are not established here.

Factors

Degree of sex-steroid deficiency, age at recognition, associated genetic cause, and treatment response.